utilized large-scale single-cell transcriptome maps to reveal the immune characteristics of COVID-19, employing BCR data to classify patients’ infection statuses based on a random forest classifier that analyzes VDJ gene usage frequency (9). This evidence concerns the gene BCR and infection.